Bod CEO ‘confident’ firm will register over-the-counter CBD medicine as insomnia trial progresses by Martin Lane March 13, 2023April 30, 2024 Bod Science CEO Jo Patterson has said the firm is “feeling confident” it will successfully register […]
Bod Science clears stability hurdle for Aqua Phase deal but PK study delayed by Steve Jones March 7, 2023April 30, 2024
Rise of THC flower hits Bod CBD sales as medical revenues fall 29% by Steve Jones February 27, 2023April 30, 2024
Company news: Avecho; Levin Health; Cannatrek; Releaf Group; Bod Science by Martin Lane and Steve Jones December 22, 2022April 29, 2024
Bod changes name to reflect focus on drug development and innovation by Steve Jones December 14, 2022April 29, 2024